ETON PHARMACEUTICALS INC. - COMMON STOCK
13.44
10-January-25 15:45:00
15 minutes delayed
Stocks
+1.43
+11.91%
Today's range
11.63 - 13.46
ISIN
N/A
Source
NASDAQ
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 Jun 2021 09:37:52 By Nasdaq GlobeNewswire
-
28 May 2021 07:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 May 2021 15:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 Mar 2021 15:02:00 By Nasdaq GlobeNewswire
-
04 Mar 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 Jan 2021 07:00:01 By Nasdaq GlobeNewswire